American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer

Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer

2013 • 12,861 citations

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

2005 • 7,244 citations

A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer

2004 • 5,895 citations

American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer

2006 • 4,319 citations

Cancer incidence, mortality and prevalence worldwide

2004 • 3,893 citations

American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer

2007 • 2,145 citations

Estrogen Receptor Status by Immunohistochemistry Is Superior to the Ligand-Binding Assay for Predicting Response to Adjuvant Endocrine Therapy in Breast Cancer

1999 • 1,991 citations

American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer

2007 • 1,788 citations

ON THE TREATMENT OF INOPERABLE CASES OF CARCINOMA OF THE MAMMA: SUGGESTIONS FOR A NEW METHOD OF TREATMENT, WITH ILLUSTRATIVE CASES.

1896 • 1,633 citations

Effects of Tamoxifen vs Raloxifene on the Risk of Developing Invasive Breast Cancer and Other Disease Outcomes<SUBTITLE>The NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 Trial</SUBTITLE>

2006 • 1,621 citations

Mechanisms of Estrogen Receptor Signaling: Convergence of Genomic and Nongenomic Actions on Target Genes

2005 • 1,297 citations

American Society of Clinical Oncology Technology Assessment on the Use of Aromatase Inhibitors As Adjuvant Therapy for Postmenopausal Women With Hormone Receptor–Positive Breast Cancer: Status Report 2004

2004 • 1,051 citations

Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999.

2000 • 1,034 citations

Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies.

1985 • 995 citations

The value of estrogen and progesterone receptors in the treatment of breast cancer

1980 • 735 citations

Estrogen Receptors in Human Breast Cancer

1973 • 673 citations

Estrogen Receptors in Human Breast Cancer

1976 • 621 citations

Outcome Prediction for Estrogen Receptor-Positive Breast Cancer Based on Postneoadjuvant Endocrine Therapy Tumor Characteristics

2008 • 610 citations

Predicting Response to Endocrine Therapy in Human Breast Cancer: A Hypothesis

1975 • 570 citations

Quantification of immunohistochemistry—issues concerning methods, utility and semiquantitative assessment II

2006 • 570 citations

Tamoxifen Resistance in Breast Tumors Is Driven by Growth Factor Receptor Signaling with Repression of Classic Estrogen Receptor Genomic Function

2008 • 481 citations

Relationship Between Quantitative Estrogen and Progesterone Receptor Expression and Human Epidermal Growth Factor Receptor 2 (HER-2) Status With Recurrence in the Arimidex, Tamoxifen, Alone or in Combination Trial

2008 • 436 citations

Prognostic and Predictive Value of Centrally Reviewed Expression of Estrogen and Progesterone Receptors in a Randomized Trial Comparing Letrozole and Tamoxifen Adjuvant Therapy for Postmenopausal Early Breast Cancer: BIG 1-98

2007 • 435 citations

Use of a monoclonal anti-estrogen receptor antibody in the immunohistochemical evaluation of human tumors.

1986 • 386 citations

Progesterone Receptors as a Prognostic Factor in Stage II Breast Cancer

1983 • 372 citations

Prognostic significance of progesterone receptor levels in estrogen receptor-positive patients with metastatic breast cancer treated with tamoxifen: results of a prospective Southwest Oncology Group study.

1992 • 360 citations

Steroid Hormone Receptors

1976 • 345 citations

Reliability of immunohistochemical demonstration of oestrogen receptors in routine practice: interlaboratory variance in the sensitivity of detection and evaluation of scoring systems

2000 • 328 citations

Estrogen receptor (ER) and progesterone receptor (PgR), by ligand-binding assay compared with ER, PgR and pS2, by immuno-histochemistry in predicting response to tamoxifen in metastatic breast cancer: A Southwest Oncology Group study

2000 • 309 citations

Influence of Synthetic Oestrogens on Advanced Malignant Disease

1944 • 298 citations

Treatment of Primary Breast Cancer with Chemotherapy and Tamoxifen

1981 • 289 citations

American Society of Clinical Oncology Clinical Practice Guideline Update on the Use of Pharmacologic Interventions Including Tamoxifen, Raloxifene, and Aromatase Inhibition for Breast Cancer Risk Reduction

2009 • 283 citations

Progesterone receptor by immunohistochemistry and clinical outcome in breast cancer: a validation study

2004 • 283 citations

Survival With Aromatase Inhibitors and Inactivators Versus Standard Hormonal Therapy in Advanced Breast Cancer: Meta-analysis

2006 • 278 citations

Lower-Dose vs High-Dose Oral Estradiol Therapy of Hormone Receptor–Positive, Aromatase Inhibitor–Resistant Advanced Breast Cancer

2009 • 277 citations

Minimum Formalin Fixation Time for Consistent Estrogen Receptor Immunohistochemical Staining of Invasive Breast Carcinoma

2003 • 269 citations

Benefit from adjuvant tamoxifen therapy in primary breast cancer patients according oestrogen receptor, progesterone receptor, EGF receptor and HER2 status

2006 • 266 citations

Influence of tumor estrogen and progesterone receptor levels on the response to tamoxifen and chemotherapy in primary breast cancer.

1983 • 264 citations

HER-2 Amplification, HER-1 Expression, and Tamoxifen Response in Estrogen Receptor-Positive Metastatic Breast Cancer

2004 • 256 citations

Immunohistochemical determination of oestrogen receptor: comparison of different methods of assessment of staining and correlation with clinical outcome of breast cancer patients

1996 • 241 citations

Estrogen- and Progesterone-Receptor Status in ECOG 2197: Comparison of Immunohistochemistry by Local and Central Laboratories and Quantitative Reverse Transcription Polymerase Chain Reaction by Central Laboratory

2008 • 230 citations

Expanding Priorities — Confronting Chronic Disease in Countries with Low Income

2007 • 200 citations

Immunohistochemical Detection Using the New Rabbit Monoclonal Antibody SP1 of Estrogen Receptor in Breast Cancer Is Superior to Mouse Monoclonal Antibody 1D5 in Predicting Survival

2006 • 196 citations

Frequency of oestrogen and progesterone receptor positivity by immunohistochemical analysis in 7016 breast carcinomas: correlation with patient age, assay sensitivity, threshold value, and mammographic screening

2000 • 180 citations

Re-evaluating Adjuvant Breast Cancer Trials: Assessing Hormone Receptor Status by Immunohistochemical Versus Extraction Assays

2006 • 158 citations

High Progesterone Receptor Expression Correlates to the Effect of Adjuvant Tamoxifen in Premenopausal Breast Cancer Patients

2006 • 144 citations

Estrogen Receptor Analysis for Breast Cancer

2005 • 136 citations

Oophorectomy and Tamoxifen Adjuvant Therapy in Premenopausal Vietnamese and Chinese Women With Operable Breast Cancer

2002 • 131 citations

Consensus Recommendations on Estrogen Receptor Testing in Breast Cancer By Immunohistochemistry

2008 • 131 citations

Immunohistochemical and molecular subtypes of breast cancer in Nigeria

2007 • 123 citations

Recommendations for Validating Estrogen and Progesterone Receptor Immunohistochemistry Assays

2010 • 115 citations

Prognostic usefulness of estrogen receptor immunocytochemical assays for human breast cancer.

1986 • 114 citations

Tissue Array Technology for Testing Interlaboratory and Interobserver Reproducibility of Immunohistochemical Estrogen Receptor Analysis in a Large Multicenter Trial

2002 • 109 citations

Chemoendocrine Compared With Endocrine Adjuvant Therapies for Node-Negative Breast Cancer: Predictive Value of Centrally Reviewed Expression of Estrogen and Progesterone Receptors—International Breast Cancer Study Group

2008 • 107 citations

Effect of Prolonged Formalin Fixation on the Immunohistochemical Reactivity of Breast Markers

2002 • 105 citations

Immunohistochemical evaluation of hormone receptor status for predicting response to endocrine therapy in metastatic breast cancer

2006 • 103 citations

Recommendations for validating estrogen and progesterone receptor immunohistochemistry assays.

2010 • 103 citations

Detection and dynamic localisation of estradiol-receptor complexes in intact target cells by immunofluorescence technique

1976 • 94 citations

Development of Standard Estrogen and Progesterone Receptor Immunohistochemical Assays for Selection of Patients for Antihormonal Therapy

2007 • 84 citations

Immunohistochemical assessment for estrogen receptor and progesterone receptor status in breast cancer: Analysis for a cut-off point as the predictor for endocrine therapy

2004 • 76 citations

Massive estrogen administration in premenopausal women with metastatic breast cancer

1962 • 71 citations

Estrogen-receptor interactions in target tissues.

1967 • 67 citations

Influence of Fixation, Antibody Clones, and Signal Amplification on Steroid Receptor Analysis

1998 • 64 citations

Differences in Breast Cancer Risk Factors by Tumor Marker Subtypes among Premenopausal Vietnamese and Chinese Women

2005 • 60 citations

Minimum Formalin Fixation Time for Consistent Estrogen Receptor Immunohistochemical Staining of Invasive Breast Carcinoma

2003 • 56 citations

Unmasking the Mysteries of Antigen or Epitope Retrieval and Formalin Fixation

2004 • 54 citations

Historical perspective on hormonal therapy of advanced breast cancer

2002 • 52 citations

Unmasking the Mysteries of Antigen or Epitope Retrieval and Formalin Fixation

2004 • 49 citations

Adjuvant ovarian ablation vs CMF chemotherapy in premenopausal breast cancer patients: trial update and impact of immunohistochemical assessment of ER status

2002 • 49 citations

Frequency and reliability of oestrogen receptor, progesterone receptor and HER2 in breast carcinoma determined by immunohistochemistry in Australasia: results of the RCPA Quality Assurance Program

2007 • 47 citations

Sex steroids, growth factors and mammographic density: a cross-sectional study of UK postmenopausal Caucasian and Afro-Caribbean women

2009 • 45 citations

Estrogen receptor assay: Interlaboratory and intralaboratory variations in the measurement of receptors using dextran-coated charcoal technique: A study sponsored by E.C.O.G.

1981 • 44 citations

Hormone receptors in primary and advanced breast cancer

1980 • 36 citations

Potential for False-Positive Staining With a Rabbit Monoclonal Antibody to Progesterone Receptor (SP2)

2008 • 36 citations

Immunohistochemical staining of estrogen and progesterone receptors: aspects for evaluating positivity and defining the cutpoints.

2005 • 34 citations

Comparison of sex steroid receptor determinations in human breast cancer by enzyme immunoassay and radioligand binding

1990 • 32 citations

A simple index using video image analysis to predict disease outcome in primary breast cancer

1999 • 32 citations

Quantitative immunohistochemical assay for hormonal receptors: technical aspects and biological significance.

1994 • 31 citations

Immunohistochemical detection of progesterone receptor in formalin-fixed and paraffin-embedded breast cancer tissue using a monoclonal antibody

1990 • 28 citations

Oestrogen receptor in breast cancer: prognostic studies using a new immunohistochemical assay

1990 • 24 citations

A randomised study of the effects of letrozole and anastrozole on oestrogen receptor positive breast cancers in postmenopausal women

2008 • 23 citations

Immunohistochemical quantitation of oestrogen receptors and proliferative activity in oestrogen receptor positive breast cancer.

1995 • 21 citations

Facilitating consensus by examining patterns of treatment effects

2009 • 18 citations

Regulatory issues in tumor marker development

2002 • 16 citations

Establishment of Uniformity in Steroid Receptor Analyses Used in Cooperative Clinical Trials of Breast Cancer Treatment

1980 • 14 citations

Markers of endocrine sensitivity

2008 • 13 citations

Precision in estrogen and progesterone receptor assays. Results of the first CAP pilot survey.

1982 • 13 citations

Co-expressed type of ER and HER2 protein as a predictive factor in determining resistance to antiestrogen therapy in patients with ER-positive and HER2-positive breast cancer

2005 • 11 citations

Therapy for cancer of the breast. Current status of steroid hormone receptors.

1979 • 10 citations

An assessment of current achievements in the systemic management of breast cancer

1984 • 9 citations

Computer-assisted immunocytochemical determination of breast cancer steroid receptors. Frozen sections vs paraffin sections

2001 • 7 citations